The U.S. Food Drug Administration (FDA) has approved EXCENEL® RTU EZ (ceftiofur hydrochloride) Sterile Suspension for the treatment and control of swine respiratory disease. New EXCENEL® RTU EZ is an improved formulation which makes injections easier for user convenience.
Pfizer reports that EXCENEL® RTU EZ is significantly more syringeable when compared to EXCENEL® RTU. Another enhancement is its new yellow skirt color for easier bottle identification of open vials by users.
The intramuscular injection of EXCENEL® RTU EZ establishes therapeutic plasma concentrations in less than one hour to effectively treat and control a broad spectrum of pathogens that cause swine respiratory disease including Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis and Streptococcus suis type 2.
The product should be administered intramuscularly in swine and requires no refrigeration or reconstitution. For full prescribing information, visit www.EXCENELRTUEZ.com.
EXCENEL® RTU EZ should not be used in animals found to be hypersensitive to the product. EXCENEL® RTU EZ has a pre-slaughter withdrawal period of 4 days.
Source: Pfizer Animal Health Press Release